IRIS
FURNARI, MANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.138
AS - Asia 1.587
NA - Nord America 1.087
SA - Sud America 108
AF - Africa 31
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.980
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.840
US - Stati Uniti d'America 1.007
SG - Singapore 582
CN - Cina 414
VN - Vietnam 252
FR - Francia 115
BD - Bangladesh 97
BR - Brasile 62
HK - Hong Kong 59
CA - Canada 47
GB - Regno Unito 47
DE - Germania 34
IN - India 33
FI - Finlandia 26
IQ - Iraq 25
AR - Argentina 24
JP - Giappone 23
MX - Messico 22
AU - Australia 21
ES - Italia 16
ID - Indonesia 16
NL - Olanda 14
SA - Arabia Saudita 13
TR - Turchia 12
EC - Ecuador 11
PH - Filippine 10
IR - Iran 8
PK - Pakistan 8
TH - Thailandia 8
JO - Giordania 7
UA - Ucraina 7
CH - Svizzera 6
KE - Kenya 5
AT - Austria 4
CL - Cile 4
EG - Egitto 4
ET - Etiopia 4
IE - Irlanda 4
JM - Giamaica 4
MA - Marocco 4
UZ - Uzbekistan 4
DZ - Algeria 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RU - Federazione Russa 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CO - Colombia 2
CZ - Repubblica Ceca 2
FJ - Figi 2
HU - Ungheria 2
LV - Lettonia 2
PE - Perù 2
PL - Polonia 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MR - Mauritania 1
NP - Nepal 1
PF - Polinesia Francese 1
PY - Paraguay 1
SE - Svezia 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
UG - Uganda 1
Totale 15.980
Salva come PNG Salva come JPEG
Città #
Genova 7.131
Genoa 3.658
Vado Ligure 945
Rapallo 930
Singapore 261
San Jose 260
Ashburn 147
Lauterbourg 105
Ho Chi Minh City 77
Beijing 74
New York 74
Council Bluffs 60
Hanoi 60
Hong Kong 56
Santa Clara 28
Frankfurt am Main 24
Los Angeles 23
Orem 23
Tokyo 22
Milan 21
Bordighera 20
Helsinki 19
Boardman 16
Da Nang 13
Mexico City 12
Montreal 12
Phoenix 12
Amsterdam 11
Rome 11
Toronto 11
Buffalo 10
Mumbai 10
Naples 10
Athens 9
Haiphong 9
Jeddah 9
São Paulo 9
Baghdad 8
Erbil 8
London 8
Wallsend 8
Amman 7
Brisbane 7
Lappeenranta 7
Tianjin 7
Chicago 6
Dallas 6
Hải Dương 6
Jersey City 6
Memphis 6
Shanghai 6
Zurich 6
Boston 5
Chennai 5
City of London 5
Cleveland 5
Guangzhou 5
Melbourne 5
Nairobi 5
Poplar 5
Seattle 5
Addis Ababa 4
Bologna 4
Buenos Aires 4
Bắc Ninh 4
Can Tho 4
Columbus 4
Conway 4
Dublin 4
Islamabad 4
Kyiv 4
Lynnwood 4
Manila 4
Modena 4
Murcia 4
Newcastle upon Tyne 4
Ninh Bình 4
Padua 4
Quito 4
San Francisco 4
Santa Barbara 4
Shenzhen 4
Sydney 4
Tashkent 4
Vancouver 4
Atlanta 3
Auckland 3
Bangkok 3
Beaufort 3
Brooklyn 3
Bình Phước 3
Calgary 3
Camden 3
Cardiff 3
Changsha 3
Charlotte 3
Curitiba 3
Florence 3
Fortaleza 3
Friendswood 3
Totale 14.470
Salva come PNG Salva come JPEG
Nome #
Side effects of long-term use of proton pump inhibitors: practical considerations 257
Proton pump inhibitors: use and misuse in the clinical setting 239
Incidental physiological sliding hiatal hernia: a single center comparison study between CT with water enema and CT colonography 225
The sensory system of the esophagus--what do we know? 223
Comparison of adenoma miss rate and adenoma detection rate between conventional colonoscopy and colonoscopy with second-generation distal attachment cuff: a multicenter, randomized, back-to-back trial 208
Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index 206
Advancements in the use of manometry and impedance testing for esophageal functional disorders 206
Measurement of oro-caecal transit time by magnetic resonance imaging. 204
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 201
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 200
A safety review of proton pump inhibitors to treat acid-related digestive diseases 199
Barrett's esophagus in 2016: From pathophysiology to treatment 197
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 195
Comparison of Two Different Techniques to Assess Adalimumab Trough Levels in Patients with Crohn's Disease. 193
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 189
Gastric and masticatory performances in full-arch immediate loading rehabilitated patients 188
Breath tests to assess alcoholic liver disease. 186
Caution About Overinterpretation of Number of Reflux Episodes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease 185
Comparison of computed tomography and magnetic resonance imaging in the discrimination of intraperitoneal and extraperitoneal rectal cancer: initial experience 182
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 181
Association Between Baseline Impedance Values and Response Proton Pump Inhibitors in Patients With Heartburn 179
A Closer Look at Factors Associated With Bleeding in Cirrhotic Patients 178
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. 177
Current treatment options for esophageal diseases. 177
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Patients With Reflux Disease 175
Degree of colonic distension: intrapatient comparison between CT colonography and CT with water enema 171
Data on symptom association analysis in patients undergoing endoscopic therapy is useful to better define a successful therapeutic approach 170
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations 167
Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: the perfect storm 159
Harmonising proton pump inhibitors treatment in the specialist setting following the SIGE recommendations 158
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 156
Microscopic Esophagitis, Baseline Impedance and Post-Reflux Swallow-Induced Peristaltic Wave in Functional Heartburn: Useful Diagnostic Tools. 156
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 155
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin 155
Optimal management of constipation associated with irritable bowel syndrome. 154
The appropriate use of proton-pump inhibitors 154
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 149
The natural history of gastro-esophageal reflux disease: A comprehensive review 146
The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring 145
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 143
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 143
Feasibility of the cut-and-push method for removing large caliber, soft, percutaneous endoscopic gastrostomy devices. 142
Overweight is a risk factor for both erosive and non-erosive reflux disease. 142
Esophagogastric junction morphology assessment by high resolution manometry in obese patients candidate to bariatric surgery 141
Tryciclic Antidepressants in Refractory GERD: Poorly Effective Drugs or Wrong Patients? 139
It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients. 139
Course of oesophageal varices and performance of non-invasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease 139
Voluntary and controlled weight loss can reduce symptoms and proton pump inhibitor use and dosage in patients with gastroesophageal reflux disease: A comparative study 137
Manually calculated oesophageal bolus clearance time increases in parallel with reflux severity at impedance-pH monitoring 137
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 137
Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn 136
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 136
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders. 134
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 134
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 134
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD. 134
Gastrointestinal involvement in systemic sclerosis 134
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 134
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 133
Gastrointestinal motility disorder assessment in systemic sclerosis. 131
Letter: it is time to adopt new objective parameters to accurately identify patients with functional heartburn 131
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 130
Full-Dose Peginterferon Alfa-2a and Low-Dose Ribavirin Treatment of Genotypes 1 and 4 Chronic Hepatitis C Patients With End-Stage Renal Disease. 126
Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? 126
Hepatocellular carcinoma is the most frequent final diagnosis of focal liver lesions identified in a cross-sectional evaluation of patients with chronic liver disease in Saudi Arabia. 125
Esophageal testing: What we have so far 124
Sniffing out causes of gastrointestinal disorders: A review of volatile metabolomic biomarkers 123
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 122
Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants. 122
Letter: faecal volatile organic metabolites, promising biomarkers in inflammatory bowel disease. 121
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool. 121
Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV 121
Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time 120
M01822 Diagnostic accuracy and Inter/Intra-observer Agreement between endoscopists with different expertise, before and after a short training, for the detection of gastric intestinal metaplasia by means of narrow band imaging with magnifying endoscopy 119
Applicability of Parameters for the Non-Invasive Diagnosis of Esophageal Varices Needing Treatment to Cured HCV Patients 119
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough 116
NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis 116
Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data 115
High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: A comparison with surgical in vivo evaluation 115
Signet ring cell carcinoma of the stomach: correlation between endocytoscopy and histology 114
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered 114
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 113
Prevalence of active H. pylori infection and clarithromycin-contatining triple therapy efficacy in patients with dyspepsia-experience of a tertiary centre in North of Italy 110
Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir 109
Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. 108
Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure 108
Treatment of early stage chronic hepatitis C virus infection 107
Esophageal motor disorders across ages: A retrospective multicentric analysis 106
Extending landscape of volatile metabolites as novel diagnostic biomarkers of inflammatory bowel disease - a review 105
Polyp and endoscopist-related factors influencing complication rates in difficult colonic polypectomies: results of a multicenter observational study 101
Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection. 100
Esophageal baseline impedance values correlate with presence and severity of microscopic esophagitis in patients with gastro-esophaeal reflux disease 98
Hepatocellular Carcinoma Intermediate Stage Subclassification Systems: One, None, and One Hundred Thousand 98
Letter: Treatment for small intestinal bacterial overgrowth - Where are we now? 94
Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors. 94
Intra- and interobserver Agreement between endoscopists and pathologists for detection of gastric intestinal metaplasia by means of narrow band imaging with magnifying endoscopy 91
Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective? 90
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 89
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 89
Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high‐resolution manometry studies 88
Totale 14.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.290
article - articoli 52.865
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 425
Totale 106.580
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/20221.209 82 31 69 121 35 128 44 304 80 141 38 136
2022/20231.122 123 107 28 85 189 152 6 92 212 6 111 11
2023/2024708 34 96 10 92 70 116 55 28 23 24 46 114
2024/20252.348 100 144 99 159 301 275 161 362 91 90 273 293
2025/20264.794 521 129 558 331 565 434 644 234 400 509 361 108
Totale 16.529